Hydroxycarbamide Pharmacenter (Hydroxycarbamide)

Hydroxycarbamide inhibits the enzyme ribonucleotide reductase, which is essential for DNA synthesis. By limiting the supply of deoxyribonucleotides, it slows the proliferation of rapidly dividing cells, particularly abnormal hematopoietic cells, thereby exerting its therapeutic effect.

The dose of Hydroxycarbamide Pharmacenter is individualized by the prescribing clinician based on the specific indication, disease severity, laboratory values and patient tolerance. Only a qualified healthcare professional should determine the appropriate dosing regimen.

Safety of hydroxycarbamide during pregnancy and lactation has not been established; the product carries an unknown pregnancy category. It should be used only when the potential benefit justifies the possible risk, and the decision must be made in consultation with a physician.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Hydroxycarbamide is an oral ribonucleotide‑reductase inhibitor, whereas alternatives such as interferon‑α or busulfan have different mechanisms and administration routes. Hydroxycarbamide offers convenient oral dosing but may have a higher risk of marrow suppression, while interferon‑α is injectable and can cause flu‑like symptoms. Choice depends on disease, patient preference and safety profile.

Store the product at ambient temperature below 25 °C in its original container, protecting it from moisture and direct sunlight. Keep the medication out of reach of children and avoid exposure to extreme heat or humidity.

Hydroxycarbamide is taken orally, usually with a full glass of water. It may be taken with or without food, according to the prescribing clinician’s instructions. Patients should follow the exact dosing schedule and not alter the regimen without medical advice.

The most serious risks include bone‑marrow suppression leading to anemia, neutropenia or thrombocytopenia; severe infections due to immunosuppression; hepatotoxicity with elevated liver enzymes; and rare allergic reactions such as angioedema. Patients should be monitored regularly for these complications.

Hydroxycarbamide should be avoided in patients with known hypersensitivity to the drug, those with active severe infections, and pregnant women unless the therapeutic benefit outweighs the risk. Caution is also advised for individuals with significant renal or hepatic impairment.